No menu items!

The Race for a Vaccine

Scientists are racing to make a vaccine for the coronavirus, collaborating across borders in what is usually a secretive and competitive field. But their cooperation has been complicated by national leaders trying to buy first claim on any breakthrough. Today, we explore how the fight to own a future coronavirus vaccine is revealing the boundaries of international solidarity.

Guest: Katrin Bennhold, Berlin bureau chief for The New York Times, spoke with Lidia Oostvogels, who researches infectious diseases with the German biotech company CureVac. For more information on today’s episode, visit nytimes.com/thedaily.

Background reading:

All-in-One
Alternative Bank Solution
Highly secured Crypto Trading Platform
Checkout IXFI Friendly Crypto Exchange

More from author

Related posts

AdvertismentIXFI Friendly Exchange

Latest posts

Top 5 cryptocurrencies to watch this week: BTC, BNB, XMR, ETC, MANA

BTC price continues to encounter selling pressure, but a brief rally or the start of consolidation could lead to sharp gains in BNB, XMR,...

What is total value locked (TVL) in crypto and why does it matter?

DeFi participants must be aware of the total value locked (TVL) indicator.Find out here what it is, how it is calculated and why it...

Dollar Cost Averaging or Lump-sum: Which Bitcoin strategy works best regardless of price?

A dollar invested into Bitcoin every month since December 2017 has provided investors a cumulative return of $160.

Want to stay up to date with the latest news?

We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!